Systematic review and meta-analysis explore EBV's role as a risk factor for aggressive prostate cancer, suggesting key implications.
This study highlights EBV as a possible risk factor for aggressive prostate cancer (PCa). Additional research is necessary to explore how EBV proteins contribute to PCa development.
No takes yet. Share an insight, caveat, or question.
Abidi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: